Arbela Laboratories, Inc. — Form D

Arbela Laboratories, Inc. of RANDOLPH, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-01. The offering totals $1.5M, of which $575K was reported sold. Industry: Other.

Offering

• Filed: 2024-04-01
• Form: D
• Accession: 0002013446-24-000001
• Industry: Other
• Exemptions: 04, 06b, 4a5
• Total offering: $1.5M
• Amount sold: $575K
• Remaining: $925K
• Minimum investment: $25K
• Investors: 12
• Date of first sale: 2024-03-18
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-509259

Issuer

• Name: Arbela Laboratories, Inc.
• CIK: 0002013446
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 41 WILKESHIRE BLVD., RANDOLPH, NJ, 07869
• Phone: (518) 588-6042

Officers, directors & promoters (3)

More

• CIK 2013446 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search